文獻: A chemical-enhanced system for CRISPR-Based nucleic acid detection (2021)nLi, Z., Zhao, W., Ma, S., Li, Z., Yao, Y., & Fei, T. A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection. (2020)nKaminski M., Alcantar M., Lape I., et.al. A CRISPR-based lateral flow assay for plant genotyping and pathogen diagnostics (2022)nSánchez, E., Ali, Z., Islam, T., Mahfouz, M., & Mahfouz, M. M. A CRISPR-Cas12a-based diagnostic method for multiple genotypes of severe fever with thrombocytopenia syndrome virus (2022)nJu, B., P., Rae, J., Y., Heo, S. T., Kim, M., Lee, K. H., & Songid, Y.-J. A CRISPR-Cas12a-based platform facilitates the detection and serotyping of Streptococcus suis serotype 2 (2024)nWang, L., Sun, J., Zhao, J., Bai, J., Zhang, Y., Zhu, Y., Zhang, W., Wang, C., Langford, P. R., Liu, S., & Li, G. A Fast and Simple DNA Mini-barcoding and RPA Assay Coupled with Lateral Flow Assay for Fresh and Canned Mackerel Authentication (2022)nFrigerio, J., Gorini, T., Palumbo, C., de Mattia, F., Labra, M., & Mezzasalma, V. Milenia Biotec是全球知名的臨床快速檢測試劑條的研發(fā)、生產(chǎn)和銷售商之一。臨床快速檢測試劑條開發(fā)原料供應(yīng)商,作為專注于開發(fā)和生產(chǎn)用于臨床診斷和研究領(lǐng)域的快速免疫分析產(chǎn)品的領(lǐng)導(dǎo)者,Milenia Biotec致力于提供高質(zhì)量、可靠性和易于操作的產(chǎn)品,以滿足醫(yī)療行業(yè)的需求。